Table 2.
Schematic representation of ADMET and TOPKAT properties of ComAI and its derivatives.
Name | Structure | Docking score/interaction site | Toxicity prediction(ADMET and TOPKAT) | ||||
---|---|---|---|---|---|---|---|
Rule of 3 and rule of 5 | QPlogHERG | QPlogBB | QPlogKhsa | Human oral absorption (%) | |||
ComAI | ![]() |
−3.088 Q11 |
![]() |
![]() |
![]() |
![]() |
100 |
Derivatives of ComAI | |||||||
ComAI1 | ![]() |
−3.815 Q11 |
![]() |
![]() |
![]() |
![]() |
100 |
ComAI2 | ![]() |
−3.334 Q11,Q95 |
![]() |
![]() |
![]() |
![]() |
100 |
ComAI3 | ![]() |
−3.214 Q11, Q47, L94 |
![]() |
![]() |
![]() |
![]() |
86.7 |
ComAI4 | ![]() |
−3.342 Q11,Q95 |
![]() |
![]() |
![]() |
![]() |
100 |
ComAI' | ![]() |
−0.485 – |
![]() |
![]() |
![]() |
![]() |
– |
Toxicity free behavior.